<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations/><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/67B34D05-3A52-4A09-8FF9-F2398D60E246"><gtr:id>67B34D05-3A52-4A09-8FF9-F2398D60E246</gtr:id><gtr:name>University of Surrey</gtr:name><gtr:department>Microbial &amp; Cellular Sciences</gtr:department><gtr:address><gtr:line1>Registry</gtr:line1><gtr:line2>Stag Hill</gtr:line2><gtr:line4>Guildford</gtr:line4><gtr:line5>Surrey</gtr:line5><gtr:postCode>GU2 7XH</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/67B34D05-3A52-4A09-8FF9-F2398D60E246"><gtr:id>67B34D05-3A52-4A09-8FF9-F2398D60E246</gtr:id><gtr:name>University of Surrey</gtr:name><gtr:address><gtr:line1>Registry</gtr:line1><gtr:line2>Stag Hill</gtr:line2><gtr:line4>Guildford</gtr:line4><gtr:line5>Surrey</gtr:line5><gtr:postCode>GU2 7XH</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/3E4B71E4-4D20-440B-866E-59163B36824F"><gtr:id>3E4B71E4-4D20-440B-866E-59163B36824F</gtr:id><gtr:firstName>Jian-Mei</gtr:firstName><gtr:surname>Li</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=BB%2FD009510%2F1"><gtr:id>923E7541-06C7-48DF-813D-61F987E0E595</gtr:id><gtr:title>NADPH OXIDASE- REGULATION OF ENDOTHELIAL CELL CYCLE PROGRESSION</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>BB/D009510/1</gtr:grantReference><gtr:abstractText>Endothelial cell growth, death and function are important determinant related to many diseases including diabetes, atherosclerosis, heart failure and even aging. Very recently it was discovered that endothelial cell function and cell fate are tightly coupled to the cellular redox state. Controlled endogenous reactive oxygen species (ROS) generation is absolutely necessary for normal endothelial cell proliferation, angiogenesis and remodeling (cell cycle control). However, excessive ROS production causes endothelial dysfunction and even death. Endothelial cells express constitutively a multicomponent NADPH oxidase, which is a major source of superoxide generation. The catalytic subunit of NADPH oxidase has 5 isoforms named Nox1-5, and at least 3 of them (Nox1, 2 and 4) are found in endothelial cells. Our hypothesis is that different Nox isoforms of NADPH oxidase may control differently the activity of this enzyme, and then regulate the redox state and the fate of endothelial cells. The overall aim of the project is to investigate the mechanisms of NADPH oxidase regulation of endothelial cell cycle progression. In particular, we wish to examine the differences in the roles of Nox2 and Nox4 (2 major Nox isoforms of NADPH oxidase) in control the levels and the location of ROS production in endothelial cells, which may be involved in the decision making process of cell proliferation, growth arrest or even death. This project will provide us with the fundamental information on redox-regulation of endothelial cell cycle progression, and the role of NADPH oxidase in endothelial cell function and vascular biology.</gtr:abstractText><gtr:technicalSummary>Aim 1. To examine the levels of expression of Nox isoforms in endothelial cells (EC) under growth arrest versus proliferating or TNF alpha-induced apoptosis. A characteristic of EC is that they stop dividing when reaching confluence, and stay at monolayer and quiescent (G0/G1 phase). It provides us a perfect window to determine the basal Nox isoform expression. We propose to use a human microvascular EC line (HMEC1) and a mouse vascular EC line (SVEC4) because they are easy to propagate and standardise. Cells (~70% confluent) will be serum starved for 24-48 h (growth arrest) before stimulation with serum (0-20%) (proliferating) in the presence or absence of TNF alpha (NADPH oxidase stimulator, 5-200 units/mL) for 0-48 hours. Inhibitors of NADPH oxidase (DPI or apocynin), superoxide scavenger (Tiron), antioxidant (N-acetylcysteine) and superoxide dismutase mimetic (MnTMPyP) will be used to confirm the role of NADPH oxidase and ROS. Peroxide (5-500 micromole) in the presence or absence of serum will be used in parallel experiments to help assessing the direct role of ROS in EC proliferation or apoptosis. Nox isoform expression will be examined at mRNA level by quantitative real-time RT-PCR, and at protein level by immunoblotting. Cell proliferation will be detected by both cell number counting and a non-radioactive (MTS) kit from Promega LtD. Cell apoptosis will be assayed by both early DNA damage using a H2A.X phosphorylation assay kit from Upstate LtD and TUNEL assay. The numbers of cells in G0/G1, S and G2/M phase under different culture conditions will be assessed by FACS analysis. Aim 2. To investigate the relationship between the levels of Nox2 and Nox4 expression, O2- production, and cell cycle progression. We plan to use coronary microvascular EC (CMEC) isolated from Nox2 knockout (KO) and matched wild-type mice in order to get direct information about Nox2 and indirect information about Nox4. We will manipulate the expression levels of Nox2 and Nox4 in these cells by in vitro transfection of sense (overexpresssion) or antisense (depletion) cDNAs. We have been given the full length Nox2 cDNA and Nox4 cDNA. These cDNAs will be subcloned with sense or antisense orientations into a mammalian cell expression vector PcDNA3.1 and used for EC transfection. Wild-type and Nox2 KO CMEC will be transfected with these constructs using Lipofectamine 2000 Plus (Invitrogen) exactly as reported recently by the PI. The protein expression of Nox2 or Nox4 in these cells will be examined by immunoblotting after 48 h of transfection. Cells after transfection will be subjected to growth arrest, proliferation, or incubated with TNF alpha to induce apoptosis. NADPH oxidase activity will be assessed by measuring superoxide generation using 3 different methods complementary to each other: lucigenin-chemiluminescence, SOD-inhibitable Cyt c reduction assay and DHE fluorescence for intact cells. The level of ROS generation will be correlated to the levels of Nox2 and Nox4 expression and the cell cycle profiles. Aim 3. To discover the differences between the subcellular location of Nox2 and Nox4 in proliferating and quiescent EC. This will be examined by two complimentary methods of subcellular protein fractionation and immunofluorescence confocol microscopy as described previously by the PI. The whole cell proteins extracted from EC at different cell cycle stage will be separated into membrane, mitochondria, submitochondria, nuclei and cytoskeleton, and cytoplasm enriched fractions by differential centrifugation. The NADPH oxidase activity and the expression of Nox2 and Nox4 in these fractions will be determined. For intact cells, EC will be cultured onto chamber slide and subjected to growth arrest, proliferation, or apoptosis. The subcellular location of Nox2 and Nox4 in these cells will be visualised by immunofluorescence confocal microscopy. The level of ROS production in these cells will be detected in parallel by DHE fluorescence.</gtr:technicalSummary><gtr:fund><gtr:end>2009-09-19</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/2512EF1C-401B-4222-9869-A770D4C5FAC7"><gtr:id>2512EF1C-401B-4222-9869-A770D4C5FAC7</gtr:id><gtr:name>BBSRC</gtr:name></gtr:funder><gtr:start>2006-03-20</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>237336</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs/><gtr:disseminationOutputs/><gtr:exploitationOutputs/><gtr:furtherFundingOutputs/><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>9A0D9E71-7747-4C3B-9923-957653781ADB</gtr:id><gtr:title>Nox2 regulates endothelial cell cycle arrest and apoptosis via p21cip1 and p53.</gtr:title><gtr:parentPublicationTitle>Free radical biology &amp; medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fc27a420a34dd56bd49a7afae769cb6a"><gtr:id>fc27a420a34dd56bd49a7afae769cb6a</gtr:id><gtr:otherNames>Li JM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0891-5849</gtr:issn><gtr:outcomeId>567589d5d9fb7</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A3BB4520-3759-48C0-B0C4-FCCB581A1296</gtr:id><gtr:title>Adenosine A2A receptor signaling regulation of cardiac NADPH oxidase activity.</gtr:title><gtr:parentPublicationTitle>Free radical biology &amp; medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0c95c41618ce2af00eb9a82e0371429e"><gtr:id>0c95c41618ce2af00eb9a82e0371429e</gtr:id><gtr:otherNames>Rib? D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0891-5849</gtr:issn><gtr:outcomeId>56758a11e4b74</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>29FAFBDF-E190-4B7E-862A-692FBD7DCB09</gtr:id><gtr:title>Chronic cocaine-induced cardiac oxidative stress and mitogen-activated protein kinase activation: the role of Nox2 oxidase.</gtr:title><gtr:parentPublicationTitle>The Journal of pharmacology and experimental therapeutics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b50fcc74f45b7c8890606bca5d3de360"><gtr:id>b50fcc74f45b7c8890606bca5d3de360</gtr:id><gtr:otherNames>Fan L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0022-3565</gtr:issn><gtr:outcomeId>56758b1e25afe</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>88257886-C01A-44A2-874C-BDEA286799BA</gtr:id><gtr:title>Knockout of p47 phox uncovers a critical role of p40 phox in reactive oxygen species production in microvascular endothelial cells.</gtr:title><gtr:parentPublicationTitle>Arteriosclerosis, thrombosis, and vascular biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2de467143cea15e27a1c1b291ae78308"><gtr:id>2de467143cea15e27a1c1b291ae78308</gtr:id><gtr:otherNames>Fan LM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1079-5642</gtr:issn><gtr:outcomeId>56758c2907eb1</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">BB/D009510/1</gtr:identifier></gtr:identifiers><gtr:healthCategories/><gtr:researchActivities/><gtr:researchSubjects/><gtr:researchTopics><gtr:researchTopic><gtr:id>D05BC2E0-0345-4A3F-8C3F-775BC42A0819</gtr:id><gtr:text>Unclassified</gtr:text></gtr:researchTopic></gtr:researchTopics><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>